earnings
VA
NASDAQ · VALN
Valneva SE
Healthcare · Biotechnology
$5.32
Down-$0.13 (-2.39%)
Updated Nov 3, 2026, 3:28 AM
SID Score
3.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 752.57M
- P/E ratio
- -9.07
- Dividend yield
- 0.00%
- 52-week range
- $4.75 – $12.18
- Volume
- 7.47K
- Avg. volume
- 41.67K
Price performance · VALN
VALN price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
VALN closed at $5.32 after 21 trading sessions, down 8.51% for the selected period.
- Last close
- $5.32
- Period change
- -8.51%
- Period low
- $5.26
- Period high
- $5.93
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $5.347 | $5.37 | $5.3114 | $5.32 | 7.47K |
| Oct 30, 2026 | $5.61 | $5.61 | $5.40 | $5.45 | 7.93K |
| Oct 29, 2026 | $5.77 | $5.77 | $5.65 | $5.71 | 11.52K |
| Oct 28, 2026 | $5.60 | $5.74 | $5.57 | $5.74 | 3.85K |
| Oct 27, 2026 | $5.43 | $5.58 | $5.38 | $5.57 | 16.13K |
| Oct 26, 2026 | $5.37 | $5.475 | $5.32 | $5.41 | 21.3K |
| Oct 23, 2026 | $5.2573 | $5.295 | $5.25 | $5.26 | 6.41K |
| Oct 22, 2026 | $5.49 | $5.61 | $5.31 | $5.36 | 22.62K |
| Oct 21, 2026 | $5.75 | $5.75 | $5.5301 | $5.56 | 137.26K |
| Oct 20, 2026 | $5.54 | $5.84 | $5.54 | $5.69 | 13.1K |
| Oct 19, 2026 | $5.53 | $5.53 | $5.40 | $5.51 | 9.14K |
| Oct 16, 2026 | $5.87 | $5.87 | $5.58 | $5.61 | 9.48K |
| Oct 15, 2026 | $5.84 | $5.91 | $5.77 | $5.91 | 8.68K |
| Oct 14, 2026 | $5.66 | $5.73 | $5.61 | $5.66 | 22.52K |
| Oct 13, 2026 | $5.89 | $5.89 | $5.55 | $5.56 | 28.75K |
| Oct 12, 2026 | $5.86 | $5.96 | $5.85 | $5.93 | 10.52K |
| Oct 9, 2026 | $5.81 | $5.81 | $5.73 | $5.78 | 5.61K |
| Oct 8, 2026 | $5.612 | $5.74 | $5.612 | $5.69 | 11.26K |
| Oct 7, 2026 | $5.8676 | $5.99 | $5.8676 | $5.87 | 26.27K |
| Oct 6, 2026 | $6.04 | $6.04 | $5.78 | $5.86 | 19.06K |
| Oct 5, 2026 | $5.89 | $5.985 | $5.70 | $5.815 | 69.38K |
Latest VALN news
The latest Smart Investors Daily articles mentioning VALN.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

